Modifying CAR T-cells to kill solid tumours
New company created to tackle paediatric cerebral palsy
Strategic partnership to advance space-based life sciences research infrastructure
HanchorBio receives FDA Orphan Drug Designation for gastric cancer drug
Skin damage protein ID could lead to new therapies
Origami Therapeutics and Ipsen to advance protein degrader programme
IQVIA and Boehringer Ingelheim announce data collaboration
Next-generation biopreservation for cell therapy
Predicting cancer evolution
Base to Base biotech podcast 45: Chronic pain, urology, Affibody molecules and radioligand therapy
Johnson & Johnson prostate cancer drug receives CHMP positive opinion
Breakthru Medicine emerges from stealth to develop cancer drugs